SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-14-006428
Filing Date
2014-09-05
Accepted
2014-09-05 09:45:29
Documents
5
Period of Report
2014-09-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k090314_soligenix.htm 8-K 26053
2 ASSET PURCHASE AGREEMENT f8k090314ex10i_soligenix.htm EX-10.1 308224
3 REGISTRATION RIGHTS AGREEMENT DATED f8k090314ex10ii_soligenix.htm EX-10.2 131259
4 PRESS RELEASE f8k090314ex99i_soligenix.htm EX-99.1 22012
5 GRAPHIC image_001.gif GRAPHIC 3972
  Complete submission text file 0001213900-14-006428.txt   494563
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 141084703
SIC: 2834 Pharmaceutical Preparations